Acne is a chronic inflammatory disorder of the pilosebaceous unit in which barrier impairment may amplify discomfort and inflammatory tone. Increased sebum production, abnormal lipid composition, excessive keratinization, microbial dysbiosis, and inflammatory responses in patients with acne vulgaris can all contribute to skin barrier damage.^[1] Retinoids, benzoyl peroxide, and keratolytics are effective but may cause dryness, peeling, stinging, erythema, increased transepidermal water loss (TEWL), and reduced adherence. Early moisturization is particularly relevant in patients with post-cleansing tightness, prior retinoid intolerance, sensitive phenotypes, combination therapy, environmental stress, or low adherence risk. Ceramides are structural lipids that combine with cholesterol and fatty acids to maintain organized intercellular lamellae, limit TEWL, retain hydration, and support barrier repair and resilience.^[2] Ceramide replenishment can improve barrier comfort, reduce dryness and irritation, and facilitate continued evidence-based acne therapy. Thus, ceramide moisturizers should be positioned as adjunctive, acne-compatible barrier support—not stand-alone acne treatment, while active acne therapy remains the foundation of management.